Payal Sahni's Insider Trades & SAST Disclosures
Payal Sahni's most recent trade in Pfizer Inc. was a trade of 206,569 Stock Appreciation Rights done . Disclosure was reported to the exchange on March 4, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Payal Sahni.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Pfizer Inc. | Payal Sahni | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 206,569 | 206,569 | - | - | Stock Appreciation Rights | |
| Pfizer Inc. | Payal Sahni | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.31 per share. | 27 Feb 2025 | 19,054 | 44,242 (0%) | 0% | 31.3 | 596,581 | Common Stock |
| Pfizer Inc. | Payal Sahni | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 19,054 | 0 | - | - | Stock Appreciation Rights | |
| Pfizer Inc. | Payal Sahni | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.06 per share. | 27 Feb 2025 | 17,846 | 25,928 (0%) | 0% | 26.1 | 465,067 | Common Stock |
| Pfizer Inc. | Payal Sahni | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.10 per share. | 27 Feb 2025 | 468 | 43,774 (0%) | 0% | 26.1 | 12,215 | Common Stock |
| Pfizer Inc. | Payal Sahni | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.17 per share. | 22 Feb 2025 | 12,714 | 37,099 (0%) | 0% | 30.2 | 383,581 | Common Stock |
| Pfizer Inc. | Payal Sahni | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2025 | 12,714 | 0 | - | - | Stock Appreciation Rights | |
| Pfizer Inc. | Payal Sahni | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.08 per share. | 22 Feb 2025 | 11,343 | 25,188 (0%) | 0% | 26.1 | 295,825 | Common Stock |
| Pfizer Inc. | Payal Sahni | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.30 per share. | 22 Feb 2025 | 568 | 36,531 (0%) | 0% | 26.3 | 14,938 | Common Stock |
| Pfizer Inc. | Payal Sahni | Executive Vice President | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Sep 2024 | 45,920 | 0 | - | - | Stock Appreciation Rights | |
| Pfizer Inc. | Payal Sahni | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2024 | 45,920 | 45,920 | - | - | Stock Appreciation Rights | |
| Pfizer Inc. | Payal Sahni | Executive Vice President | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Sep 2024 | 42,265 | 0 | - | - | Stock Appreciation Rights | |
| Pfizer Inc. | Payal Sahni | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2024 | 42,265 | 42,265 | - | - | Stock Appreciation Rights | |
| Pfizer Inc. | Sahni Payal | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 71,627 | 71,627 | - | - | Stock Appreciation Rights | |
| Pfizer Inc. | Sahni Payal | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 63,289 | 63,289 | - | - | Stock Appreciation Rights | |
| Pfizer Inc. | Payal Sahni | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.34 per share. | 23 Feb 2024 | 11,527 | 34,604 (0%) | 0% | 27.3 | 315,148 | Common Stock |
| Pfizer Inc. | Payal Sahni | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 11,527 | 0 | - | - | Stock Appreciation Rights | |
| Pfizer Inc. | Sahni Payal | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.37 per share. | 23 Feb 2024 | 9,314 | 24,385 (0%) | 0% | 27.4 | 254,924 | Common Stock |
| Pfizer Inc. | Sahni Payal | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.76 per share. | 23 Feb 2024 | 905 | 33,699 (0%) | 0% | 27.8 | 25,123 | Common Stock |
| Pfizer Inc. | Payal Sahni | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.89 per share. | 25 Feb 2023 | 8,921 | 30,127 (0%) | 0% | 22.9 | 204,202 | Common Stock |
| Pfizer Inc. | Payal Sahni | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2023 | 8,921 | 0 | - | - | Stock Appreciation Rights | |
| Pfizer Inc. | Payal Sahni | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.44 per share. | 25 Feb 2023 | 3,967 | 24,374 (0%) | 0% | 43.4 | 172,326 | Common Stock |
| Pfizer Inc. | Payal Sahni | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.75 per share. | 25 Feb 2023 | 1,786 | 28,341 (0%) | 0% | 41.8 | 74,566 | Common Stock |
| Pfizer Inc. | Payal Sahni | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.78 per share. | 25 Feb 2023 | 1,297 | 23,077 (0%) | 0% | 40.8 | 52,892 | Common Stock |
| Pfizer Inc. | Payal Sahni | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2023 | 45,920 | 45,920 | - | - | Stock Appreciation Rights | |
| Pfizer Inc. | Payal Sahni | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2023 | 39,965 | 39,965 | - | - | Stock Appreciation Rights | |
| Pfizer Inc. | Payal Sahni | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.17 per share. | 22 Feb 2023 | 15,209 | 32,671 (0%) | 0% | 30.2 | 458,856 | Common Stock |
| Pfizer Inc. | Payal Sahni | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2023 | 15,209 | 0 | - | - | Stock Appreciation Rights | |
| Pfizer Inc. | Payal Sahni | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.70 per share. | 22 Feb 2023 | 9,259 | 21,206 (0%) | 0% | 43.7 | 404,618 | Common Stock |
| Pfizer Inc. | Payal Sahni | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.38 per share. | 22 Feb 2023 | 2,206 | 30,465 (0%) | 0% | 42.4 | 93,490 | Common Stock |
| Pfizer Inc. | Payal Sahni | Executive Vice President | Sale of securities on an exchange or to another person at price $ 49.84 per share. | 13 May 2022 | 1,408 | 17,372 (0%) | 0% | 49.8 | 70,175 | Common Stock |
| Pfizer Inc. | Payal Sahni | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 4,295 | 4,295 | - | - | Phantom Stock Units | |
| Pfizer Inc. | Payal Sahni | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.94 per share. | 28 Feb 2022 | 1,049 | 18,753 (0%) | 0% | 46.9 | 49,240 | Common Stock |
| Pfizer Inc. | Payal Sahni | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2022 | 42,265 | 42,265 | - | - | Stock Appreciation Rights | |
| Pfizer Inc. | Payal Sahni | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2022 | 37,172 | 37,172 | - | - | Stock Appreciation Rights | |
| Pfizer Inc. | Payal Sahni | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.34 per share. | 23 Feb 2022 | 13,884 | 29,391 (0%) | 0% | 27.3 | 379,589 | Common Stock |
| Pfizer Inc. | Payal Sahni | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2022 | 13,884 | 0 | - | - | Stock Appreciation Rights | |
| Pfizer Inc. | Payal Sahni | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.28 per share. | 23 Feb 2022 | 6,872 | 19,802 (0%) | 0% | 51.3 | 352,396 | Common Stock |
| Pfizer Inc. | Payal Sahni | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.87 per share. | 23 Feb 2022 | 2,717 | 26,674 (0%) | 0% | 46.9 | 127,346 | Common Stock |
| Pfizer Inc. | Payal Sahni | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 56,888 | 56,888 | - | - | Stock Appreciation Rights | |
| Pfizer Inc. | Payal Sahni | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 49,153 | 49,153 | - | - | Stock Appreciation Rights | |
| Pfizer Inc. | Payal Sahni | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2021 | 9,982 | 0 | - | - | Stock Appreciation Rights | |
| Pfizer Inc. | Payal Sahni | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.89 per share. | 25 Feb 2021 | 9,982 | 22,949 (0%) | 0% | 22.9 | 228,488 | Common Stock |
| Pfizer Inc. | Payal Sahni | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.76 per share. | 25 Feb 2021 | 6,460 | 15,292 (0%) | 0% | 34.8 | 224,550 | Common Stock |
| Pfizer Inc. | Payal Sahni | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.82 per share. | 25 Feb 2021 | 1,197 | 21,752 (0%) | 0% | 33.8 | 40,483 | Common Stock |
| Pfizer Inc. | Payal Sahni | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.26 per share. | 22 Feb 2021 | 1,172 | 12,967 (0%) | 0% | 34.3 | 40,153 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges